irritable bowel syndrome

FDA approves Actavis, Valeant drugs for irritable bowel syndrome
Yahoo/Reuters
Wed, 05/27/15 - 08:27 pm
FDA
Actavis
Valeant Pharmaceuticals
IBS
irritable bowel syndrome
Xifaxan
Viberzi
Takeda targets gastrointestinal disease with its latest R&D deal
Fierce Biotech
Thu, 12/11/14 - 11:52 am
Takeda
R&D
irritable bowel syndrome
Ardelyx irritable bowel syndrome drug succeeds in mid-stage trial
Reuters
Wed, 10/1/14 - 08:19 am
Ardelyx
IBS
irritable bowel syndrome
tenapanor
AstraZeneca Pharma India
Furiex Diarrhea Drug May Lure Takeover by Salix: Real M&A
Bloomberg
Wed, 03/19/14 - 03:55 pm
Salix
Furiex Pharmaceuticals
M&A
eluxadoline
irritable bowel syndrome
Furiex Said to Seek Buyer as Experimental Drug Meets Targets
Bloomberg
Wed, 02/19/14 - 12:48 pm
Furiex Pharmaceuticals
eluxadoline
M&A
irritable bowel syndrome
Pipeline Progress at Synergy Pharma
Yahoo/Zacks
Sat, 07/20/13 - 11:03 am
Synergy Pharmaceuticals
irritable bowel syndrome
plecanatide
Ironwood's Bowel Drug Sales Disappoint
TheStreet.com
Tue, 04/23/13 - 10:47 am
Ironwood
Linzess
Forest Labs
irritable bowel syndrome
IBS
SP-333 Targets Root Cause Of Irritable Bowel Syndrome
Motley Fool
Sun, 02/24/13 - 02:31 pm
SP-333
irritable bowel syndrome
Synergy Pharmaceuticals
10 Drugs Approved by the FDA in 2012 to Be Thankful For
Motley Fool
Sat, 12/15/12 - 01:28 pm
Xtandi
Medivation
prostate cancer
Stribild
Gilead Sciences
HIV
Belviq
Arena Pharmaceuticals
obesity
weight loss
Qsymia
Vivus
Kyprolis
ONYX Pharmaceuticals
Multiple Myeloma
Omontys
Affymax
anemia
Linzess
irritable bowel syndrome
Ironwood Pharmaceuticals
Bosulif
chronic myeloid leukemia
Pfizer
Amyvid
Alzheimer's disease
Eli Lilly
Eylea
macular degeneration
Regeneron
Sucampo Announces Approval for Updates to AMITIZA; Endo Health Solutions Stock Halted Following News
Equities.com
Sat, 12/1/12 - 10:52 am
Sucampo
Amitiza
Endo Health Solutions
irritable bowel syndrome
Sucampo Pharmaceuticals, Inc. : Sucampo Presents Data for AMITIZA® in the Treatment of Moderate to Very Severe Irritable Bowel Syndrome with Constipation (IBS-C)
4-Traders
Sun, 05/20/12 - 12:35 pm
Sucampo
Amitiza
irritable bowel syndrome
Yet Another Delay for Forest Labs
Yahoo/Zacks
Wed, 04/25/12 - 10:31 am
Forest Labs
Ironwood Pharmaceuticals
linaclotide
irritable bowel syndrome
Tioga nabs $10M VC deal amid PhIII for bowel disorder drug
Fierce Biotech
Fri, 04/13/12 - 10:51 am
Tioga
venture capital
D-IBS
irritable bowel syndrome
Series B
asimadoline
FDA gives fast-track status to Tioga irritable bowel drug
San Diego Union Tribune, CA
Thu, 06/2/11 - 10:47 am
irritable bowel syndrome
FDA
IBS
Tioga
fast track
Salix's IBS drug fails to get FDA nod
Reuters
Tue, 03/8/11 - 11:48 am
FDA
Salix
IBS
irritable bowel syndrome
Xifaxan
Salix Tanks After Drug Setback
Minyanville
Thu, 02/24/11 - 11:32 pm
Salix
Xiafaxan
IBS
irritable bowel syndrome
Key Data Approaching for Lexicon's Mid-Stage Pipeline
Morningstar
Sat, 11/6/10 - 01:08 pm
Lexicon Pharmaceuticals
LX2931
arthritis
LX1032
carcinoid syndrome
LX1031
irritable bowel syndrome
Ironwood, Forest boast positive IBS drug trial
Yahoo/AP
Tue, 09/14/10 - 08:06 am
IBS
irritable bowel syndrome
Ironwood
Forest Labs
linaclotide
Lexicon says IBS drug met mid-stage study goal
Yahoo/AP
Sat, 11/14/09 - 12:40 pm
IBS
irritable bowel syndrome
Lexicon Pharmaceuticals